Clinical Trials Browser

Colorectal Neoplasms

NCT07453875 2026-03-06

TRIUNITE06

Phase 1 Not yet recruiting

9 enrolled

Gastrointestinal

Colorectal Neoplasms

NCT07417488 2026-02-27

GUCY2C Prime-Boost Vaccination for Advanced Colorectal and Small Bowel Adenocarcinomas

Phase 1 Not yet recruiting

18 enrolled

Gastrointestinal

Colorectal Neoplasms

NCT07272642 2026-02-25

DUNP19

Phase 1 Not yet recruiting

16 enrolled

BreastGastrointestinalHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Colorectal Neoplasms, Triple Negative Breast Neoplasms

NCT07411781 2026-02-17

PIN in Combination With Sintilimab in Previously Treated pMMR/MSS CRC With Hepatic Metastases

Phase 1 Not yet recruiting

25 enrolled

Gastrointestinal

Colorectal Neoplasms

NCT07409805 2026-02-13

YMN-136 Vaccine for Patients With Liver Metastasis of Colorectal Cancer Progressing After Third-Line Treatment

Phase 1 Not yet recruiting

9 enrolled

Gastrointestinal

Colorectal Neoplasms

NCT07363408 2026-01-23

Ivonescimab and ADG126, Alone, and in Combination With Leucovorin and Fluorouracil or FOLFIRI Regimen for the Treatment of Microsatellite Stable Advanced/Metastatic Colorectal Cancer

Phase 1 Not yet recruiting

30 enrolled

Gastrointestinal

Colorectal Neoplasms

NCT07358884 2026-01-22

First in Human Study of QLS5316 in Solid Tumors

Phase 1 Not yet recruiting

300 enrolled

GastrointestinalHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Stomach Neoplasms, Colorectal Neoplasms

NCT06283134 2026-01-07

A Clinical Study of BioTTT001 in Combination With Toripalimab and Regorafenib in Patients With Colorectal Cancer

Phase 1 Not yet recruiting

60 enrolled

Gastrointestinal

Colorectal Neoplasms

NCT07036185 2025-06-25

A Clinical Trail of KJ015 in Patients With HER2-Expressing Solid Tumors

Phase 1 Not yet recruiting

66 enrolled

BreastGastrointestinalHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Bile Duct Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Colorectal Neoplasms

NCT07031011 2025-06-22

PD-1-M1-NK Cells in the Treatment of Advanced Gastric or Colorectal Cancer

Phase 1 Not yet recruiting

22 enrolled

Gastrointestinal

Colorectal Neoplasms

NCT07014878 2025-06-11

A Study of DCTY1102 Injection in Patients With Advanced Solid Tumors

Phase 1 Not yet recruiting

110 enrolled

Gastrointestinal

Colorectal Neoplasms

NCT06963502 2025-05-09

A Phase Ib Study of HS-10370 in Addition to Other Anti-cancer Therapies in Patients With Advanced Solid Tumors

Phase 1 Not yet recruiting

762 enrolled

GastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Colorectal Neoplasms

NCT06948539 2025-04-29

To Evaluate the Tolerability and Pharmacokinetics of TQB2101 for Injection in Patients With Advanced Malignant Tumors

Phase 1 Not yet recruiting

66 enrolled

BreastGastrointestinalThoracic

Breast Neoplasms, Lung Neoplasms, Colorectal Neoplasms

NCT04062721 2025-04-06

LICoRN-01

Phase 1 Not yet recruiting

12 enrolled

Gastrointestinal

Colorectal Neoplasms

NCT06882915 2025-03-19

Efficacy and Safety of Trifluridine/tipiracil (TAS-102) Combined with Bevacizumab and Putalimab in the Treatment of Patients with MCRC After Cytoreductive Surgery: a Single-arm, Single-center Clinical Study

Phase 1 Not yet recruiting

20 enrolled

Gastrointestinal

Colorectal Neoplasms

NCT06652529 2024-11-07

AROG4-01-01

Phase 1 Not yet recruiting

35 enrolled

GastrointestinalGynecologicOther solid neoplasmThoracic

Carcinoma, Non-Small-Cell Lung, Mesothelioma, Ovarian Neoplasms, Colorectal Neoplasms

NCT06614751 2024-09-27

A PARG Inhibitor DAT-2645 Monotherapy in Patients with Advanced/Metastatic Solid Tumors Harboring BRCA1/2 Loss of Function Alterations And/or Other Defects in the DDR Pathway

Phase 1 Not yet recruiting

112 enrolled

BreastGastrointestinalGenitourinaryGynecologic

Breast Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms

Clinical Trials

A Study to Investigate CEA-PRIT 2.0 in Participants With Metastatic Colorectal Cancer (mCRC)

TRIUNITE06

GUCY2C Prime-Boost Vaccination for Advanced Colorectal and Small Bowel Adenocarcinomas

DUNP19

PIN in Combination With Sintilimab in Previously Treated pMMR/MSS CRC With Hepatic Metastases

YMN-136 Vaccine for Patients With Liver Metastasis of Colorectal Cancer Progressing After Third-Line Treatment

Ivonescimab and ADG126, Alone, and in Combination With Leucovorin and Fluorouracil or FOLFIRI Regimen for the Treatment of Microsatellite Stable Advanced/Metastatic Colorectal Cancer

First in Human Study of QLS5316 in Solid Tumors

A Clinical Study of BioTTT001 in Combination With Toripalimab and Regorafenib in Patients With Colorectal Cancer

A Clinical Trail of KJ015 in Patients With HER2-Expressing Solid Tumors

PD-1-M1-NK Cells in the Treatment of Advanced Gastric or Colorectal Cancer

A Study of DCTY1102 Injection in Patients With Advanced Solid Tumors

A Phase Ib Study of HS-10370 in Addition to Other Anti-cancer Therapies in Patients With Advanced Solid Tumors

To Evaluate the Tolerability and Pharmacokinetics of TQB2101 for Injection in Patients With Advanced Malignant Tumors

LICoRN-01

Efficacy and Safety of Trifluridine/tipiracil (TAS-102) Combined with Bevacizumab and Putalimab in the Treatment of Patients with MCRC After Cytoreductive Surgery: a Single-arm, Single-center Clinical Study

AROG4-01-01

A PARG Inhibitor DAT-2645 Monotherapy in Patients with Advanced/Metastatic Solid Tumors Harboring BRCA1/2 Loss of Function Alterations And/or Other Defects in the DDR Pathway